Qure.ai appoints Mihir Bhanushali as EVP, Global Health, to lead AI-powered healthcare expansion in LMICs

Qure.ai, a global AI technology company focused on healthcare, announced the appointment of Mihir Bhanushali as Executive Vice President (EVP), Global Health, as the company deepens its investment in AI-powered healthcare across low- and middle-income countries (LMICs).

Bhanushali joins Qure.ai from Freshworks, where he was Senior Director, Global Sales. A seasoned commercial leader, he has built and scaled high-growth businesses across global markets, with earlier leadership roles at Rippling and Whatfix spanning sales, go-to-market strategy and commercial transformation.

At Qure.ai, Bhanushali will lead the next phase of the company’s growth across LMICs, with a focus on Africa, Southeast Asia, South Asia and Latin America. His mandate spans the company’s solutions for infectious diseases, including tuberculosis and HIV, and care delivery across frontline health systems.

Qure.ai has built a strong public health footprint over the past decade, with its AI solutions deployed across 107+ countries and 5,200+ sites. Its work in countries such as Nigeria and Kenya demonstrates how AI can substantially strengthen public health programs — from TB screening and early diagnosis to care delivery. The company is helping nationwide public health systems build digital and AI-native infrastructure that enables healthcare workers and primary care providers to make better decisions and improve patient outcomes.

Building on this foundation, Qure.ai is expanding beyond screening and early diagnosis into broader care delivery. At the centre of this expansion is Aira, Qure.ai’s AI doctor and clinical co-pilot for frontline healthcare, which brings clinical intelligence, digital workflows and care coordination closer to the point of care, with applications across primary care, telemedicine, HIV, infectious diseases and pandemic preparedness.

“Improving healthcare access in low- and middle-income countries has been our ambition from day one, and we see a significant opportunity to scale our work in this space,” said Prashant Warier, Co-founder and CEO, Qure.ai. “AI can radically change healthcare workflows in these markets, and we are expanding our team to scale faster. Mihir brings strong commercial and international experience, and his mandate is to build on what we have already established and take this work to its next stage of growth, including scaling Aira across new markets and use cases.”

“Qure.ai has built something meaningful: AI technology that is already being used at scale to address real healthcare challenges across diverse markets,” said Mihir Bhanushali, Executive Vice President, Global Health, Qure.ai. “What makes the opportunity particularly exciting is the potential to take this foundation much further, bringing clinical intelligence to more frontline workers, strengthening health systems and reaching more patients. With solutions such as Aira, Qure.ai is well positioned to shape the next phase of AI-enabled healthcare in these markets.”

Qure.ai’s work in LMICs is supported by partnerships with governments, healthcare organisations and global health funders, including the Gates Foundation.